შეჯამება
განსაზღვრება
ანამნეზი და გასინჯვა
Principais fatores diagnósticos
- potential exposure to measles
- unvaccinated/incompletely vaccinated individuals
- fever
- cough
- coryza
- conjunctivitis
- Koplik spots
- maculopapular rash
Fatores de risco
- exposure to measles virus
- no prior immunization against measles
- failure to respond to measles vaccine
Investigações diagnósticas
Primeras pruebas diagnósticas para solicitar
- measles-specific IgM and IgG serology (ELISA)
Pruebas diagnósticas que deben considerarse
- acute and convalescent sera for measles-specific IgG
- measles RNA detection by PCR
- antigen detection by fluorescent antibody or PCR techniques
- isolation of virus in tissue culture system
Algoritmo de tratamiento
Colaboradores
Autores
Elizabeth Barnett, MD
Professor of Pediatrics
Boston University School of Medicine
Boston Medical Center
Boston
MA
Divulgaciones
EB receives clinical trial funds from Pfizer (COVID, PCV20, and RSV vaccines) and GSK (MMRV vaccine). She receives royalties from Elsevier (Immigrant Medicine), AAP (Nelson's antimicrobial therapy), and honoraria from AAP (Red Book). She participated in an Advisory Board (Sobi, RSV).
Revisores por pares
Sharon Nachman, MD
Professor of Pediatrics
Division Chief Pediatric Infectious Disease
State University of New York at Stony Brook
Stony Brook
NY
Divulgaciones
SN declares that she has no competing interests.
Linda Nield, MD, FAAP
Professor of Pediatrics
West Virginia University School of Medicine
Morgantown
WV
Divulgaciones
LN is an author of a reference cited in this topic.
Aisha Sethi, MD
Assistant Professor of Medicine
Associate Residency Program Director
University of Chicago
Chicago
IL
Divulgaciones
AS declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Texto completo Resumen
Centers for Disease Control and Prevention. Child and adolescent immunization schedule: recommendations for ages 18 years or younger, United States, 2025. Nov 2024 [internet publication].Texto completo
UK Health Security Agency. Measles: the green book, chapter 21. Dec 2019 [internet publication].Texto completo
Centers for Disease Control and Prevention. Adult immunization schedule: recommendations for ages 19 years or older, United States, 2025. Nov 2024 [internet publication].Texto completo
Committee on Infectious Diseases, American Academy of Pediatrics. Measles. In: Kimberlin DW, Banerjee R, Barnett ED, et al, eds. Red Book: 2024-2027 Report of the Committee on Infectious Diseases. 33rd ed. Itasca, IL: American Academy of Pediatrics; 2024.Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible aquí.
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad